• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy.热休克蛋白 70/90 组织蛋白作为囊性纤维化治疗中的硝化靶标。
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11393-8. doi: 10.1073/pnas.0909128107. Epub 2010 Jun 8.
2
S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells.S-亚硝基化剂:一类新型化合物,可增加上皮细胞中囊性纤维化跨膜传导调节因子的表达和成熟。
Mol Pharmacol. 2006 Oct;70(4):1435-42. doi: 10.1124/mol.106.023242. Epub 2006 Jul 20.
3
The CFTR-Associated Ligand Arrests the Trafficking of the Mutant ΔF508 CFTR Channel in the ER Contributing to Cystic Fibrosis.与CFTR相关的配体阻止突变型ΔF508 CFTR通道在内质网中的转运,这与囊性纤维化的发生有关。
Cell Physiol Biochem. 2018;45(2):639-655. doi: 10.1159/000487120. Epub 2018 Jan 29.
4
Augmentation of CFTR maturation by S-nitrosoglutathione reductase.通过S-亚硝基谷胱甘肽还原酶增强囊性纤维化跨膜传导调节因子(CFTR)的成熟。
Am J Physiol Lung Cell Mol Physiol. 2016 Feb 1;310(3):L263-70. doi: 10.1152/ajplung.00269.2014. Epub 2015 Dec 4.
5
S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation.S-亚硝基谷胱甘肽可促进囊性纤维化跨膜传导调节因子的成熟。
Biochem Biophys Res Commun. 2001 Jun 1;284(1):65-70. doi: 10.1006/bbrc.2001.4935.
6
Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking?基于S-亚硝基化修饰的囊性纤维化跨膜传导调节因子转运疗法可行与否?
Mol Pharmacol. 2006 Oct;70(4):1155-8. doi: 10.1124/mol.106.029207. Epub 2006 Jul 28.
7
Novel s-nitrosothiols have potential therapeutic uses for cystic fibrosis.新型 S-亚硝基硫醇对囊性纤维化具有潜在的治疗用途。
Curr Pharm Des. 2013;19(19):3509-20. doi: 10.2174/13816128113199990319.
8
Partial restoration of cAMP-stimulated CFTR chloride channel activity in DeltaF508 cells by deoxyspergualin.脱氧精胍菌素使ΔF508细胞中cAMP刺激的CFTR氯通道活性部分恢复。
Am J Physiol. 1998 Jul;275(1):C171-8. doi: 10.1152/ajpcell.1998.275.1.C171.
9
ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells.ERp29 调节 DeltaF508 和野生型囊性纤维化跨膜电导调节因子 (CFTR) 在囊性纤维化 (CF) 和非 CF 上皮细胞中的质膜转运。
J Biol Chem. 2011 Jun 17;286(24):21239-53. doi: 10.1074/jbc.M111.240267. Epub 2011 Apr 27.
10
Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR.4-苯基丁酸钠下调热休克蛋白70:对DeltaF508-囊性纤维化跨膜传导调节因子细胞内转运的影响
Am J Physiol Cell Physiol. 2000 Feb;278(2):C259-67. doi: 10.1152/ajpcell.2000.278.2.C259.

引用本文的文献

1
Mapping the oxidative landscape in cystic fibrosis: methodological frontiers and application.绘制囊性纤维化中的氧化图谱:方法前沿与应用
Front Pharmacol. 2025 Jul 16;16:1632924. doi: 10.3389/fphar.2025.1632924. eCollection 2025.
2
Antigen stasis and airway nitrosative stress in human primary ciliary dyskinesia.人原发性纤毛运动障碍中的抗原停滞和气道硝化应激。
Am J Physiol Lung Cell Mol Physiol. 2024 Apr 1;326(4):L468-L476. doi: 10.1152/ajplung.00208.2022. Epub 2024 Feb 6.
3
"NO" Time in Fear Response: Possible Implication of Nitric-Oxide-Related Mechanisms in PTSD.恐惧反应中的“无”时间:一氧化氮相关机制在 PTSD 中的可能影响。
Molecules. 2023 Dec 22;29(1):89. doi: 10.3390/molecules29010089.
4
CFTR Folding: From Structure and Proteostasis to Cystic Fibrosis Personalized Medicine.CFTR 折叠:从结构和蛋白质稳态到囊性纤维化个体化医学。
ACS Chem Biol. 2023 Oct 20;18(10):2128-2143. doi: 10.1021/acschembio.3c00310. Epub 2023 Sep 20.
5
Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration.蛋白质 S-亚硝基化和氧化导致神经退行性变中的蛋白质错误折叠。
Free Radic Biol Med. 2021 Aug 20;172:562-577. doi: 10.1016/j.freeradbiomed.2021.07.002. Epub 2021 Jul 2.
6
New Therapies to Correct the Cystic Fibrosis Basic Defect.新型疗法纠正囊性纤维化基础缺陷。
Int J Mol Sci. 2021 Jun 8;22(12):6193. doi: 10.3390/ijms22126193.
7
Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.CFTR 的转录组和蛋白质稳定网络,以及小分子调节剂治疗囊性纤维化肺病的开发。
Genes (Basel). 2020 May 13;11(5):546. doi: 10.3390/genes11050546.
8
Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.CFTR 生物发生的蛋白质稳态网络调节和药理学调节剂。
Int J Mol Sci. 2020 Jan 10;21(2):452. doi: 10.3390/ijms21020452.
9
-Nitrosylation of CHIP Enhances F508Del-CFTR Maturation.-CHIP 巯基亚硝基化增强 F508del-CFTR 的成熟。
Am J Respir Cell Mol Biol. 2019 Dec;61(6):765-775. doi: 10.1165/rcmb.2018-0314OC.
10
CK19 stabilizes CFTR at the cell surface by limiting its endocytic pathway degradation.CK19 通过限制 CFTR 的内吞途径降解来稳定其在细胞表面的表达。
FASEB J. 2019 Nov;33(11):12602-12615. doi: 10.1096/fj.201901050R. Epub 2019 Aug 26.

本文引用的文献

1
MetaMiner (CF): a disease-oriented bioinformatics analysis environment.
Methods Mol Biol. 2009;563:353-67. doi: 10.1007/978-1-60761-175-2_18.
2
Search and rescue: finding ways to correct deltaF508 CFTR.搜索与救援:寻找纠正ΔF508囊性纤维化跨膜传导调节因子的方法。
Am J Respir Cell Mol Biol. 2009 Apr;40(4):385-7. doi: 10.1165/rcmb.2008-0006ED.
3
Nitrosothiol reactivity profiling identifies S-nitrosylated proteins with unexpected stability.亚硝基硫醇反应性分析鉴定出具有意外稳定性的S-亚硝基化蛋白。
Chem Biol. 2008 Dec 22;15(12):1307-16. doi: 10.1016/j.chembiol.2008.10.013.
4
S-nitrosylated S100A8: novel anti-inflammatory properties.S-亚硝基化的S100A8:新型抗炎特性。
J Immunol. 2008 Oct 15;181(8):5627-36. doi: 10.4049/jimmunol.181.8.5627.
5
Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs.CFTR基因的破坏在新生猪中产生了囊性纤维化模型。
Science. 2008 Sep 26;321(5897):1837-41. doi: 10.1126/science.1163600.
6
Interactions of S100A2 and S100A6 with the tetratricopeptide repeat proteins, Hsp90/Hsp70-organizing protein and kinesin light chain.S100A2和S100A6与四肽重复序列蛋白、热休克蛋白90/热休克蛋白70组织蛋白及驱动蛋白轻链的相互作用
J Biol Chem. 2008 Oct 17;283(42):28246-58. doi: 10.1074/jbc.M801473200. Epub 2008 Jul 31.
7
Structural studies on the co-chaperone Hop and its complexes with Hsp90.辅助伴侣蛋白Hop及其与Hsp90复合物的结构研究。
J Mol Biol. 2008 Jun 13;379(4):732-44. doi: 10.1016/j.jmb.2008.02.013. Epub 2008 Feb 14.
8
Update in cystic fibrosis 2007.2007年囊性纤维化的最新进展
Am J Respir Crit Care Med. 2008 May 15;177(10):1058-61. doi: 10.1164/rccm.200801-069UP.
9
CFTR function and prospects for therapy.囊性纤维化跨膜传导调节因子的功能及治疗前景。
Annu Rev Biochem. 2008;77:701-26. doi: 10.1146/annurev.biochem.75.103004.142532.
10
Microtubule/organelle motility assays.微管/细胞器运动分析
Curr Protoc Cell Biol. 2001 May;Chapter 13:Unit 13.1. doi: 10.1002/0471143030.cb1301s00.

热休克蛋白 70/90 组织蛋白作为囊性纤维化治疗中的硝化靶标。

Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy.

机构信息

Department of Pediatric Respiratory Medicine, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

出版信息

Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11393-8. doi: 10.1073/pnas.0909128107. Epub 2010 Jun 8.

DOI:10.1073/pnas.0909128107
PMID:20534503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2895117/
Abstract

The endogenous signaling molecule S-nitrosoglutathione (GSNO) and other S-nitrosylating agents can cause full maturation of the abnormal gene product DeltaF508 cystic fibrosis (CF) transmembrane conductance regulator (CFTR). However, the molecular mechanism of action is not known. Here we show that Hsp70/Hsp90 organizing protein (Hop) is a critical target of GSNO, and its S-nitrosylation results in DeltaF508 CFTR maturation and cell surface expression. S-nitrosylation by GSNO inhibited the association of Hop with CFTR in the endoplasmic reticulum. This effect was necessary and sufficient to mediate GSNO-induced cell-surface expression of DeltaF508 CFTR. Hop knockdown using siRNA recapitulated the effect of GSNO on DeltaF508 CFTR maturation and expression. Moreover, GSNO acted additively with decreased temperature, which promoted mutant CFTR maturation through a Hop-independent mechanism. We conclude that GSNO corrects DeltaF508 CFTR trafficking by inhibiting Hop expression, and that combination therapies--using differing mechanisms of action--may have additive benefits in treating CF.

摘要

内源性信号分子 S-亚硝基谷胱甘肽(GSNO)和其他 S-亚硝酰化剂可使异常基因产物 DeltaF508 囊性纤维化(CF)跨膜电导调节剂(CFTR)完全成熟。然而,其作用的分子机制尚不清楚。本文中,我们发现热休克蛋白 70/90 组织蛋白酶(Hsp70/Hsp90) 伴侣蛋白(Hop)是 GSNO 的关键靶标,其 S-亚硝基化导致 DeltaF508 CFTR 成熟和细胞表面表达。GSNO 的 S-亚硝基化抑制了 Hop 与内质网中 CFTR 的结合。这种效应对于介导 GSNO 诱导的 DeltaF508 CFTR 细胞表面表达是必要且充分的。用 siRNA 敲低 Hop 可重现 GSNO 对 DeltaF508 CFTR 成熟和表达的影响。此外,GSNO 与降低温度具有相加作用,后者通过一种与 Hop 无关的机制促进突变 CFTR 成熟。我们得出结论,GSNO 通过抑制 Hop 表达来纠正 DeltaF508 CFTR 转运,使用不同作用机制的联合疗法可能在治疗 CF 方面具有相加益处。